Two Sigma Securities’s Fortress Biotech FBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$69K Buy
+24,744
New +$84.1K 0.01% 1221
2025
Q4
Sell
-30,474
Closed -$113K 1644
2025
Q3
$113K Buy
30,474
+16,839
+123% +$42.6K 0.02% 894
2025
Q2
$25.4K Buy
+13,635
New +$23.6K ﹤0.01% 1172
2023
Q2
Sell
-2,413
Closed -$29.7K 2947
2023
Q1
$29.7K Buy
+2,413
New +$28.7K ﹤0.01% 2319
2021
Q4
Sell
-675
Closed -$33K 1698
2021
Q3
$33K Buy
+675
New +$33K ﹤0.01% 1422
2017
Q4
Sell
-1,371
Closed -$91K 1803
2017
Q3
$91K Buy
+1,371
New +$92.4K 0.01% 684

Other funds holding FBIO

Two Sigma Securities's FBIO Position: Q1 2026 in Review

Two Sigma Securities opened a new position in Fortress Biotech (FBIO) in Q1 2026: 24,744 shares worth $69K. The stake represents 0.01% of the portfolio and ranks #1221 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in FBIO as recently as Q3 2025.

Two Sigma Securities first reported a position in FBIO in Q3 2017 and has held it in 6 quarters since. The position peaked at $113K in Q3 2025. 51 funds tracked by Wall St. Rank hold FBIO as of Q1 2026.

  • Two Sigma Securities held 24,744 shares of Fortress Biotech worth $69K as of Q1 2026.
  • Fortress Biotech was a new Two Sigma Securities position in Q1 2026.
  • Fortress Biotech made up 0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1221 holding.
  • Two Sigma Securities first reported a position in Fortress Biotech in Q3 2017 and has held it in 6 quarters since.
  • Two Sigma Securities's Fortress Biotech position peaked at $113K in Q3 2025.
  • 51 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.